$AXDX
Accelerate Diagnostics, Inc

2024 Q3 Form 10-Q Financial Statement

#000162828024036256 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.975M $2.986M
YoY Change -9.82% 2.23%
Cost Of Revenue $2.119M $2.310M
YoY Change -33.62% 8.86%
Gross Profit $856.0K $676.0K
YoY Change 756.0% -15.39%
Gross Profit Margin 28.77% 22.64%
Selling, General & Admin $5.636M $5.379M
YoY Change -27.38% -28.89%
% of Gross Profit 658.41% 795.71%
Research & Development $3.838M $3.903M
YoY Change -45.14% -32.94%
% of Gross Profit 448.36% 577.37%
Depreciation & Amortization $343.0K $351.0K
YoY Change 8.89% -0.85%
% of Gross Profit 40.07% 51.92%
Operating Expenses $9.474M $9.282M
YoY Change -35.8% -30.65%
Operating Profit -$8.618M -$8.606M
YoY Change -41.17% -31.62%
Interest Expense -$6.072M -$3.725M
YoY Change -138.75% -44.64%
% of Operating Profit
Other Income/Expense, Net -$6.021M -$2.982M
YoY Change -138.37% -85.09%
Pretax Income -$14.64M -$11.59M
YoY Change -1506.24% -64.43%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.64M -$11.59M
YoY Change -1708.68% -64.6%
Net Earnings / Revenue -492.07% -388.08%
Basic Earnings Per Share -$0.59 -$0.50
Diluted Earnings Per Share -$0.59 -$0.50
COMMON SHARES
Basic Shares Outstanding 23.68M shares 22.05M shares
Diluted Shares Outstanding 23.06M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.91M $9.746M
YoY Change 3.72% -68.26%
Cash & Equivalents $19.69M $8.588M
Short-Term Investments $1.221M $1.158M
Other Short-Term Assets $990.0K $1.114M
YoY Change -72.79% -60.38%
Inventory $2.978M $3.223M
Prepaid Expenses $529.0K $798.0K
Receivables $2.027M $2.289M
Other Receivables $0.00 $0.00
Total Short-Term Assets $27.44M $17.17M
YoY Change -15.43% -59.35%
LONG-TERM ASSETS
Property, Plant & Equipment $2.878M $3.100M
YoY Change 10.31% 7.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $763.0K $882.0K
YoY Change -31.45% -21.6%
Total Long-Term Assets $4.879M $5.697M
YoY Change -29.09% -25.42%
TOTAL ASSETS
Total Short-Term Assets $27.44M $17.17M
Total Long-Term Assets $4.879M $5.697M
Total Assets $32.32M $22.87M
YoY Change -17.82% -54.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.714M $3.759M
YoY Change -2.04% -6.79%
Accrued Expenses $2.940M $2.704M
YoY Change -14.46% -16.26%
Deferred Revenue $671.0K $791.0K
YoY Change 12.58% 65.48%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $18.26M $13.41M
YoY Change -51.68% -75.03%
LONG-TERM LIABILITIES
Long-Term Debt $58.05M $41.12M
YoY Change 72.79% 25.88%
Other Long-Term Liabilities $2.017M $2.005M
YoY Change 88.86% 82.77%
Total Long-Term Liabilities $2.017M $2.005M
YoY Change 88.86% 82.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.26M $13.41M
Total Long-Term Liabilities $2.017M $2.005M
Total Liabilities $80.80M $57.75M
YoY Change 8.66% -34.77%
SHAREHOLDERS EQUITY
Retained Earnings -$709.3M -$694.7M
YoY Change 8.15% 5.77%
Common Stock $707.0M $705.3M
YoY Change 6.11% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$48.48M -$34.89M
YoY Change
Total Liabilities & Shareholders Equity $32.32M $22.87M
YoY Change -17.82% -54.15%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$14.64M -$11.59M
YoY Change -1708.68% -64.6%
Depreciation, Depletion And Amortization $343.0K $351.0K
YoY Change 8.89% -0.85%
Cash From Operating Activities -$3.091M -$7.583M
YoY Change -62.54% -29.92%
INVESTING ACTIVITIES
Capital Expenditures -$6.000K $2.000K
YoY Change -100.79% -98.71%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $6.000K -$2.000K
YoY Change -101.71% -100.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.80M 1.396M
YoY Change -1909.78% -85.76%
NET CHANGE
Cash From Operating Activities -3.091M -7.583M
Cash From Investing Activities 6.000K -2.000K
Cash From Financing Activities 14.80M 1.396M
Net Change In Cash 11.72M -6.189M
YoY Change -224.42% 6089.0%
FREE CASH FLOW
Cash From Operating Activities -$3.091M -$7.583M
Capital Expenditures -$6.000K $2.000K
Free Cash Flow -$3.085M -$7.585M
YoY Change -65.75% -30.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-11588000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-32735000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
585000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
314000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
148.40
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
36102000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
57754000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23679383 shares
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
705280000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
694634000 usd
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
45067000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
45067000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-694675000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-668857000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-449000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-612000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-34887000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-19888000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22867000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31366000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2986000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2921000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2310000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2122000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4508000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3923000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
676000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
799000 usd
us-gaap Gross Profit
GrossProfit
1399000 usd
us-gaap Gross Profit
GrossProfit
1810000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5820000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9076000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12788000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5379000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7564000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11084000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17669000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
9282000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
13384000 usd
us-gaap Costs And Expenses
CostsAndExpenses
20160000 usd
us-gaap Costs And Expenses
CostsAndExpenses
30457000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8606000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12585000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-18761000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28647000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23058000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23058000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11009000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11009000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22250000 shares
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-5030000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
25000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-244000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
258000 usd
CY2024Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
116000 usd
CY2023Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
255000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
316000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2982000 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
41062000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23679383 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q4 us-gaap Liabilities
Liabilities
51254000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3903000 usd
CY2024Q2 axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
743000 usd
CY2023Q2 axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
0 usd
axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
743000 usd
axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
0 usd
CY2024Q2 axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-1002000 usd
CY2023Q2 axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-5030000 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-2219000 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-263000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
675000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-614000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19994000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7057000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20727000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11588000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32579000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25818000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49374000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25818000 usd
us-gaap Net Income Loss
NetIncomeLoss
-49530000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.97
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.75
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22250000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10420000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-11588000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-32735000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
169000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-26000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11419000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32757000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25818000 usd
us-gaap Net Income Loss
NetIncomeLoss
-49530000 usd
us-gaap Depreciation
Depreciation
1735000 usd
us-gaap Depreciation
Depreciation
1617000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
78000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-87000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-68000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
66000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
90000 usd
axdx Sale Of Stock Issuance Cost
SaleOfStockIssuanceCost
680000 usd
axdx Sale Of Stock Issuance Cost
SaleOfStockIssuanceCost
0 usd
axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
743000 usd
axdx Gain Loss On Extinguishment Of Accounts Payable
GainLossOnExtinguishmentOfAccountsPayable
0 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-2219000 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
-5030000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
1689000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-265000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-74000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
139000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-85000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
77000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-644000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-451000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-278000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
348000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-742000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-69000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16035000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24188000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
515000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
167000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9291000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-515000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9124000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
884000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
537000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
540000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
10000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3731000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
726000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12835000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9729000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-288000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3550000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5623000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12138000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34905000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8588000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29282000 usd
axdx Inventory Transferredto Fixed Assets
InventoryTransferredtoFixedAssets
183000 usd
axdx Inventory Transferredto Fixed Assets
InventoryTransferredtoFixedAssets
88000 usd
us-gaap Stock Issued1
StockIssued1
43000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
56893000 usd
axdx Debt Discount Premium Notes Issued
DebtDiscountPremiumNotesIssued
0 usd
axdx Debt Discount Premium Notes Issued
DebtDiscountPremiumNotesIssued
6023000 usd
axdx Derivative Liability Additions
DerivativeLiabilityAdditions
0 usd
axdx Derivative Liability Additions
DerivativeLiabilityAdditions
38160000 usd
us-gaap Interest Paid Net
InterestPaidNet
33000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-34887000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-38663000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-34887000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-38663000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-694700000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16000000.0 usd
CY2024Q2 axdx Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
3800000 usd
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
9700000 usd
axdx Increase Decrease In Cash Cash Equivalents And Short Term Investments
IncreaseDecreaseInCashCashEquivalentsAndShortTermInvestments
-3500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
13200000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to the collectability of receivables and related credit loss allowances, inventory valuation and related reserves, impairment of property and equipment, accrued liabilities, warranty liabilities, convertible notes, derivative instruments, fair value instruments, tax valuation accounts and uncertain tax positions, equity–based compensation, revenue and leases. Actual results could differ materially from those estimates.</span></div>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
559000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
314000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
590000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
324000 usd
CY2024Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
78000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
33000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
83000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
10000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
585000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
314000 usd
axdx Standard Product Warranty Instruments Term
StandardProductWarrantyInstrumentsTerm
P1Y
axdx Standard Product Warranty Kits And Accessories Term
StandardProductWarrantyKitsAndAccessoriesTerm
P60D
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
168000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
221000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
194000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
225000 usd
CY2024Q2 axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
52000 usd
CY2023Q2 axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
153000 usd
axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
84000 usd
axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
187000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
39000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
192000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
97000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
230000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
181000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
182000 usd
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
181000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
182000 usd
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2024Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1200000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1100000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
13000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
40000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
66000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
90000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1408000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1268000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
512000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
648000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1303000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1394000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3223000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3310000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14736000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13400000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11636000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11011000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3100000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2389000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
351000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
354000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
682000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
709000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
2144000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
2010000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1359000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1194000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
785000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
816000 usd
CY2024Q2 axdx Contract With Customer Liability Deferred Revenue Current
ContractWithCustomerLiabilityDeferredRevenueCurrent
383000 usd
CY2023Q4 axdx Contract With Customer Liability Deferred Revenue Current
ContractWithCustomerLiabilityDeferredRevenueCurrent
540000 usd
CY2024Q2 axdx Contract With Customer Liability Deferred Commission Current
ContractWithCustomerLiabilityDeferredCommissionCurrent
408000 usd
CY2023Q4 axdx Contract With Customer Liability Deferred Commission Current
ContractWithCustomerLiabilityDeferredCommissionCurrent
1005000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
791000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1545000 usd
CY2024Q2 axdx Contract With Customer Liability Noncurrent Research And Development Tax Incentive
ContractWithCustomerLiabilityNoncurrentResearchAndDevelopmentTaxIncentive
1134000 usd
CY2023Q4 axdx Contract With Customer Liability Noncurrent Research And Development Tax Incentive
ContractWithCustomerLiabilityNoncurrentResearchAndDevelopmentTaxIncentive
1122000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1134000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1122000 usd
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3900000 usd
CY2023Q3 axdx Contract With Customer Liability Noncurrent Research And Development Tax Incentive
ContractWithCustomerLiabilityNoncurrentResearchAndDevelopmentTaxIncentive
1100000 usd
CY2024Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
41062000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
36828000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
726000 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
41062000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
36102000 usd
CY2023Q2 us-gaap Share Price
SharePrice
7.40
CY2023Q2 us-gaap Share Price
SharePrice
7.40
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13794000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1845000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13794000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1845000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
369839 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11200 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.67
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
26046 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
160.05
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
332593 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
151.25
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
332593 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
308815 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M7D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
151.25
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
158.49
CY2024Q2 axdx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Weighted Average Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageFairValue
0
CY2024Q2 axdx Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
966000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1653000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2263000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2208000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
19000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
35000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
109000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
109000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25800000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8800000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
600000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8844000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8844000 usd
CY2023Q3 axdx Contract With Customer Liability Noncurrent Research And Development Tax Incentive
ContractWithCustomerLiabilityNoncurrentResearchAndDevelopmentTaxIncentive
1100000 usd
CY2022Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
11900000 usd
CY2024Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
11900000 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
250000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
226000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
500000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
453000 usd
CY2024Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
471000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
462000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
537000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
540000 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
200000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
200000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
245000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
243000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
490000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
493000 usd
CY2024Q2 axdx Finance Lease Cost
FinanceLeaseCost
297000 usd
CY2023Q2 axdx Finance Lease Cost
FinanceLeaseCost
270000 usd
axdx Finance Lease Cost
FinanceLeaseCost
590000 usd
axdx Finance Lease Cost
FinanceLeaseCost
531000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
31000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
19000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
49000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2024Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.072
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
500000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
217000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
583000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
86000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
30000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q2 axdx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q2 axdx Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1083000 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
333000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43000 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
25000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1040000 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
308000 usd
CY2024Q2 us-gaap Net Investment In Lease
NetInvestmentInLease
1700000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
683000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
869000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
529000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
66000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
0 usd
CY2024Q2 axdx Sales Type And Direct Financing Leases Lease Receivable To Be Received After Year Four
SalesTypeAndDirectFinancingLeasesLeaseReceivableToBeReceivedAfterYearFour
0 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
2147000 usd
CY2024Q2 axdx Sales Type And Direct Financing Leases Lease Receivable Allowances
SalesTypeAndDirectFinancingLeasesLeaseReceivableAllowances
481000 usd
CY2024Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
1666000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2986000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2921000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5907000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5733000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2986000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2921000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5907000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5733000 usd
CY2024Q2 us-gaap Lease Income
LeaseIncome
200000 usd
CY2023Q2 us-gaap Lease Income
LeaseIncome
400000 usd
us-gaap Lease Income
LeaseIncome
500000 usd
us-gaap Lease Income
LeaseIncome
600000 usd
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-036256-index-headers.html Edgar Link pending
0001628280-24-036256-index.html Edgar Link pending
0001628280-24-036256.txt Edgar Link pending
0001628280-24-036256-xbrl.zip Edgar Link pending
a06302024-exh311.htm Edgar Link pending
a06302024-exh312.htm Edgar Link pending
a06302024-exh32.htm Edgar Link pending
axdx-20240630.htm Edgar Link pending
axdx-20240630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
axdx-20240630_def.xml Edgar Link unprocessable
axdx-20240630_lab.xml Edgar Link unprocessable
axdx-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
axdx-20240630_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
axdx-20240630_cal.xml Edgar Link unprocessable